pretickt

Why is CRSP stock moving?

CRISPR Therapeutics AG · end-of-day data as of Nov 13, 2026

CRISPR Therapeutics
CRSP · $4.1B
$42.24-0.9%
Nov 13, 2026 · close
$50$60SepOctNov9:3016:003 months -20.3%Nov 13 · close
▲ 4
  • PT$72.45 +71.5%
  • ConsensusBuy · 23
  • Bollingerbelow lower
  • Sector▲ +15.9%
Neutral
  • Earnings in90d
  • RSI32
  • Support-7.6%
  • Resistance+0.3%
  • Off 52w high-33.4%
  • Volume1.2x
  • News0.00
  • Trendsideways
  • 52w range$42–$63
  • ATR+6.3%
  • Off ATH-80.8%
▼ 4
  • FCF yield-9.3%
  • Insiders-$4.88M
  • MAs0 of 4
  • MACD-0.81

Updates with the 15-min delayed price. Not a forecast or investment advice.

The move, split

CRISPR Therapeutics CRSP fell 0.9% on Nov 13, 2026.

The market (SPY) fell 0.4%; Healthcare stocks rose 0.3%. Most of the move is specific to CRISPR Therapeutics CRSP.

Market (SPY)-0.4%
Healthcare sector+0.7%
CRSP specific-1.2%

0 stories on the day (30-day average 0.8).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Context

  • News0.00
  • Volume1.2x
  • Off 52w high-33.4%
  • Sector▲ +15.9%
  • Earnings in90d

Latest news

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.